ARAY
ACCURAY INCCompany Information
- Company Name
- ACCURAY INC
- CIK
- CIK0001138723
- Category
- Accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- ARAY: Nasdaq
- Fiscal Year End
- June 30
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 3841
- SIC Description
- Surgical & Medical Instruments & Apparatus
- Ticker
- ARAY
SEC filing data through
Insider Sentiment
- Last purchase
- 2026-02-20
- Last sale
- 2024-09-04
- Shares purchased (TTM)
- 193,875
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- 2026-03-31
- Institutional shares owned
- 74,682,226
- Shares outstanding
- 124,304,000
- Ownership
- 60.08%
Earnings Market Reaction
- Filing date
- 2026-08-27
- Price on filing date
- —
- 1-month reaction
- Pending
- 3-month reaction
- Pending
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 41 | 38 | 41 | 63 | 57 | 78 | 63 | 59 | 69 | 60 | 73 | 77 | ||||||
| Restricted Cash And Cash Equivalents At Carrying Value | - | - | - | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 1 | ||||||
| Receivables Net Current | - | - | - | 54 | 83 | 78 | 87 | 92 | 92 | 73 | 77 | 77 | ||||||
| Restricted Cash Current | 1 | 0 | 1 | 1 | 1 | - | - | - | 0 | - | - | - | ||||||
| Inventory Net | 147 | 157 | 151 | 156 | 141 | 146 | 149 | 155 | 138 | 160 | 155 | 150 | ||||||
| Prepaid Expense And Other Assets Current | 32 | 33 | 37 | 29 | 34 | 29 | 25 | 21 | 23 | 19 | 25 | 29 | ||||||
| Deferred Costs Current | 0 | 0 | 2 | 0 | 2 | 1 | 0 | 2 | 1 | 1 | 0 | 1 | ||||||
| Assets Current | 288 | 293 | 292 | 304 | 317 | 333 | 326 | 330 | 323 | 314 | 331 | 334 | ||||||
Assets Noncurrent | ||||||||||||||||||
| Property Plant And Equipment Net | 27 | 29 | 29 | 29 | 29 | 27 | 27 | 25 | 25 | 25 | 26 | 25 | ||||||
| Investments In Affiliates Subsidiaries Associates And Joint Ventures | 5 | 6 | 6 | 4 | 5 | 9 | 13 | 6 | 10 | 14 | 15 | 13 | ||||||
| Operating Lease Right Of Use Asset | 28 | 29 | 33 | 32 | 33 | 34 | 32 | 33 | 34 | 29 | 23 | 24 | ||||||
| Goodwill | 58 | 58 | 58 | 58 | 58 | 58 | 58 | 58 | 58 | 58 | 58 | 58 | ||||||
| Finite Lived Intangible Assets Net | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | ||||||
| Restricted Cash And Cash Equivalents Noncurrent | - | - | - | 6 | 4 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Restricted Cash Noncurrent | 8 | 6 | 6 | 6 | 4 | - | - | - | 1 | - | - | - | ||||||
| Other Assets Noncurrent | 31 | 26 | 26 | 24 | 24 | 21 | 22 | 20 | 18 | 22 | 22 | 21 | ||||||
| Assets | 444 | 448 | 448 | 457 | 470 | 484 | 478 | 473 | 469 | 463 | 476 | 477 | ||||||
Liabilities And Stockholders Equity | ||||||||||||||||||
| Accounts Payable Current | 41 | 53 | 44 | 42 | 34 | 46 | 54 | 50 | 50 | 44 | 39 | 35 | ||||||
| Employee Related Liabilities Current | 16 | 17 | 15 | 14 | 15 | 13 | 19 | 18 | 17 | 22 | 21 | 26 | ||||||
| Operating Lease Liability Current | 8 | 8 | 8 | 7 | 7 | 7 | 8 | 7 | 6 | 5 | 6 | 6 | ||||||
| Other Accrued Liabilities Current | 32 | 26 | 31 | 26 | 29 | 35 | 28 | 25 | 29 | 31 | 36 | 37 | ||||||
| Contract With Customer Liability Current | 83 | 79 | 79 | 80 | 82 | 82 | 72 | 81 | 72 | 74 | 77 | 72 | ||||||
| Short Term Borrowings | - | - | - | 13 | 13 | 8 | 8 | 8 | 8 | 7 | 7 | 6 | ||||||
| Long Term Debt Current | 2 | 11 | 11 | 13 | 13 | - | - | - | 8 | - | - | - | ||||||
| Liabilities Current | 191 | 206 | 199 | 195 | 193 | 203 | 201 | 202 | 195 | 198 | 209 | 201 | ||||||
Liabilities Noncurrent | ||||||||||||||||||
| Operating Lease Liability Noncurrent | 28 | 29 | 30 | 31 | 32 | 33 | 30 | 32 | 32 | 28 | 22 | 23 | ||||||
| Other Liabilities Noncurrent | 5 | 7 | 6 | 5 | 5 | 6 | 6 | 7 | 7 | 5 | 5 | 5 | ||||||
| Warrants And Rights Outstanding | - | - | - | 10 | 8 | - | - | - | 0 | - | - | - | ||||||
| Derivative Liabilities Noncurrent | 2 | 3 | 6 | 10 | 8 | - | - | - | 0 | - | - | - | ||||||
| Contract With Customer Liability Noncurrent | 29 | 27 | 28 | 26 | 27 | 26 | 25 | 24 | 24 | 24 | 25 | 27 | ||||||
| Long Term Debt Noncurrent | 146 | 134 | 125 | 127 | 124 | 166 | 168 | 162 | 164 | 166 | 168 | 170 | ||||||
| Liabilities | 402 | 406 | 395 | 395 | 389 | 435 | 430 | 428 | 424 | 421 | 429 | 426 | ||||||
Stockholders Equity | ||||||||||||||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital Common Stock | - | - | - | 605 | 602 | 575 | 572 | 569 | 567 | 564 | 561 | 558 | ||||||
| Additional Paid In Capital | 614 | 611 | 609 | 605 | 602 | - | - | - | 567 | - | - | - | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -4 | -3 | -1 | -2 | -2 | -5 | -5 | -2 | -4 | -2 | 1 | -2 | ||||||
| Retained Earnings Accumulated Deficit | -568 | -567 | -555 | -541 | -519 | -520 | -519 | -522 | -518 | -521 | -515 | -505 | ||||||
| Stockholders Equity | 42 | 42 | 53 | 62 | 81 | 50 | 48 | 45 | 45 | 41 | 48 | 51 | ||||||
| Liabilities And Stockholders Equity | 444 | 448 | 448 | 457 | 470 | 484 | 478 | 473 | 469 | 463 | 476 | 477 | ||||||
| Accounts Receivable | - | - | - | 10 | 28 | -7 | -11 | 37 | 25 | -2 | -2 | 22 | ||||||
| Prepaid Expenses And Other Current Assets | - | - | - | 0 | 0 | -0 | 0 | 0 | 1 | -0 | -0 | 0 | ||||||
| Corporate Joint Venture | - | - | - | - | - | - | - | - | - | 17 | -22 | 22 | ||||||
| Allowance For Doubtful Accounts Receivable Current | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 2 | 2 | 3 | 3 | 3 | ||||||
| Accounts Receivable Net Current | 67 | 65 | 61 | 54 | 83 | - | - | - | 92 | - | - | - | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | ||||||
| Common Stock Shares Issued | 123 | 119 | 119 | 113 | 113 | 103 | 103 | 100 | 100 | 99 | 99 | 97 | ||||||
| Shares Outstanding | 119 | 119 | 119 | 113 | 113 | 103 | 103 | 100 | 100 | 99 | 99 | 97 | ||||||
| Preferred Stock Par Or Stated Value Per Share | - | - | - | - | - | - | - | - | 0.00 | - | - | - | ||||||
| Preferred Stock Shares Authorized | - | - | - | - | - | - | - | - | 5 | - | - | - | ||||||
| Preferred Stock Shares Issued | - | - | - | - | - | - | - | - | 0 | - | - | - | ||||||
| Preferred Stock Shares Outstanding | - | - | - | - | - | - | - | - | 0 | - | - | - | ||||||
Select a line item above to chart it.
Recent filings
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialACCURAY INC (ARAY) — SEC Financial Statements & Analysis
ACCURAY INC (ARAY) is a surgical & medical instruments & apparatus company, incorporated in DE. ACCURAY INC trades on Nasdaq as: ARAY. ACCURAY INC (ARAY)'s most recent SEC filing is a Form 10-K for the period ended 2026-06-30, filed with the SEC on 2026-08-27. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), ACCURAY INC carries a market cap of $31.89M, a P/E ratio of -0.65x, a P/B ratio of 0.76x, a P/S ratio of 0.08x, an enterprise value of $139.13M, and an EV/EBITDA multiple of -7.52x. On profitability, it posts a gross margin of 27.73%, an operating margin of -6.58%, a net margin of -12.24%, a Return on Equity (ROE) of -80.08%, a Return on Assets (ROA) of -10.77%, and a Return on Invested Capital (ROIC) of -15.81%. Per share, it reports EPS of $-0.40, diluted EPS of $-0.29, free cash flow per share of $-0.10, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -12.34% year-over-year, net income growth of 2992.02% year-over-year, and EPS growth of 2491.11% year-over-year. On the balance sheet, it maintains a current ratio of 1.50x, a quick ratio of 0.57x, working capital of $96.37M, a debt-to-equity ratio of 9.64x, a debt ratio of 0.91, an interest coverage ratio of -0.80x, free cash flow of $-12.84M (TTM), and net debt of $107.25M. Figures sourced from SEC EDGAR.
- Market Cap
- $31.89M
- P/E TTM
- -0.65x
- EPS TTM
- $-0.40
- P/B TTM
- 0.76x
- ROE TTM
- -80.08%
- ROA TTM
- -10.77%
- Debt To Equity
- 9.64x
- Free Cash Flow TTM
- $-12.84M
- Net Revenue TTM Growth 1Y
- -12.34%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is ACCURAY INC in?
ACCURAY INC (ARAY) operates in the Surgical & Medical Instruments & Apparatus industry.
What exchange does ARAY trade on?
ACCURAY INC (ARAY) trades on the Nasdaq.
Where is ACCURAY INC incorporated?
ACCURAY INC is incorporated in DE.
When was ACCURAY INC (ARAY)'s most recent SEC filing?
ACCURAY INC (ARAY)'s most recent SEC filing is a Form 10-K for the period ended 2026-06-30, filed with the SEC on 2026-08-27.
What is ARAY's market cap?
ACCURAY INC (ARAY) has a market capitalization of $31.89M as of 2026-06-30.
What is ARAY's EPS (earnings per share)?
ACCURAY INC (ARAY)'s trailing twelve month EPS is $-0.40 as of 2026-06-30.
What is ARAY's ROE (return on equity)?
ACCURAY INC (ARAY)'s trailing twelve month Return on Equity (ROE) is -80.08% as of 2026-06-30.
What is ARAY's ROA (return on assets)?
ACCURAY INC (ARAY)'s trailing twelve month Return on Assets (ROA) is -10.77% as of 2026-06-30.
What is ARAY's ROIC (return on invested capital)?
ACCURAY INC (ARAY)'s trailing twelve month Return on Invested Capital (ROIC) is -15.81% as of 2026-06-30.
What is ARAY's EV/EBITDA?
ACCURAY INC (ARAY)'s trailing twelve month EV/EBITDA is -7.52x as of 2026-06-30.